After a 5-weeks treatment of malonyl ginsenosides from P. quinquefolius, the fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), nonesterified fatty acid (NEFA), alanine transaminase (ALT), and aspartate transaminase (AST) levels were significantly reduced and glucose tolerance and insulin resistance were improved (Liu et al., 2021). This evidence concerns the gene GPT and glucose measurement.